{"hands_on_practices": [{"introduction": "Before we can test a hypothesis, we must first formulate it correctly. This initial exercise focuses on a critical, yet often overlooked, step: classifying hypotheses as simple or composite and ensuring they form a valid test by partitioning the entire parameter space. Understanding this formal structure is the bedrock for setting up any statistical test, as illustrated in this problem about the lifetime of a new material [@problem_id:1955259].", "problem": "A materials scientist is developing a new type of organic Light Emitting Diode (LED) for high-end displays. The operational lifetime, $T$, of a single organic LED, measured in tens of thousands of hours, is modeled by an exponential distribution with an unknown mean lifetime $\\theta$. The parameter space for the mean lifetime is therefore $\\Omega = \\{\\theta \\in \\mathbb{R} \\mid \\theta > 0\\}$.\n\nThe scientist wishes to set up a statistical hypothesis test to evaluate the performance of the new LEDs against a benchmark. A hypothesis is classified as **simple** if it completely specifies the value of the parameter $\\theta$. Otherwise, it is classified as **composite**. For a hypothesis test to be considered valid in this context, the set of parameter values defined by the null hypothesis ($H_0$) and the set defined by the alternative hypothesis ($H_1$) must be disjoint, and their union must be equal to the entire parameter space $\\Omega$.\n\nThe scientist considers the following five potential testing frameworks, where the benchmark mean lifetime is 2 (i.e., 20,000 hours):\n\n1.  **Test 1:** $H_0: \\theta = 2$ versus $H_1: \\theta = 2.5$\n2.  **Test 2:** $H_0: \\theta \\ge 2$ versus $H_1: \\theta  2$\n3.  **Test 3:** $H_0: \\theta = 2$ versus $H_1: \\theta  2.5$\n4.  **Test 4:** $H_0: \\theta \\le 2$ versus $H_1: \\theta  2$\n5.  **Test 5:** $H_0: \\theta  2$ versus $H_1: \\theta  2$\n\nBased on the definitions provided, which of the following statements is correct?\n\nA. Test 2 and Test 4 are the only valid hypothesis pairs. For both valid pairs, both the null and the alternative hypotheses are composite.\n\nB. Test 1, Test 2, and Test 4 are the only valid hypothesis pairs. For Test 1, both hypotheses are simple. For Test 2 and Test 4, both hypotheses are composite.\n\nC. All five proposed tests are valid hypothesis pairs.\n\nD. Test 2 and Test 4 are the only valid hypothesis pairs. For Test 2, the null hypothesis is composite and the alternative is simple. For Test 4, both hypotheses are composite.\n\nE. Test 1, Test 3, and Test 5 are the only valid hypothesis pairs.", "solution": "The parameter space is $\\Omega=\\{\\theta\\in\\mathbb{R}:\\theta0\\}=(0,\\infty)$. A hypothesis is simple if it specifies a single value of $\\theta$ (a singleton subset of $\\Omega$), and composite otherwise. A valid hypothesis pair must satisfy: (i) the sets defined by $H_{0}$ and $H_{1}$ are disjoint, and (ii) their union equals $\\Omega$.\n\nAnalyze each test:\n\nTest 1: $H_{0}:\\theta=2$ and $H_{1}:\\theta=2.5$. Then $H_{0}=\\{2\\}$ and $H_{1}=\\{2.5\\}$. These are disjoint, but $\\{2\\}\\cup\\{2.5\\}=\\{2,2.5\\}\\neq(0,\\infty)=\\Omega$. Hence invalid. Both hypotheses are simple.\n\nTest 2: $H_{0}:\\theta\\ge 2$ and $H_{1}:\\theta2$. Intersecting with $\\Omega$, we have $H_{0}=[2,\\infty)$ and $H_{1}=(0,2)$. They are disjoint and $[2,\\infty)\\cup(0,2)=(0,\\infty)=\\Omega$. Hence valid. Both hypotheses are composite.\n\nTest 3: $H_{0}:\\theta=2$ and $H_{1}:\\theta2.5$. Then $H_{0}=\\{2\\}$ and $H_{1}=(2.5,\\infty)$. Disjoint, but $\\{2\\}\\cup(2.5,\\infty)\\neq(0,\\infty)$. Hence invalid. $H_{0}$ is simple and $H_{1}$ is composite.\n\nTest 4: $H_{0}:\\theta\\le 2$ and $H_{1}:\\theta2$. Intersecting with $\\Omega$, $H_{0}=(0,2]$ and $H_{1}=(2,\\infty)$. They are disjoint and $(0,2]\\cup(2,\\infty)=(0,\\infty)=\\Omega$. Hence valid. Both hypotheses are composite.\n\nTest 5: $H_{0}:\\theta2$ and $H_{1}:\\theta2$. Then $H_{0}=(0,2)$ and $H_{1}=(2,\\infty)$. They are disjoint, but $(0,2)\\cup(2,\\infty)=(0,\\infty)\\setminus\\{2\\}\\neq\\Omega$. Hence invalid. Both hypotheses are composite.\n\nTherefore, only Test 2 and Test 4 are valid, and for both, both hypotheses are composite. This corresponds to option A.", "answer": "$$\\boxed{A}$$", "id": "1955259"}, {"introduction": "A simple hypothesis, which completely specifies the parameter of interest, allows for the direct calculation of a p-value from first principles. This exercise demonstrates this fundamental calculationâ€”the probability of observing data as or more extreme than what we found, assuming the null hypothesis is true. By working with a Cauchy distribution, you will reinforce the core concept of the p-value beyond simply looking up values in a standard table [@problem_id:1955212].", "problem": "A physicist is investigating the properties of a novel semiconductor material. According to a theoretical model, a specific optical transition in this material should have a peak energy of $E_0$. Due to environmental interactions and inherent quantum uncertainty, a single energy measurement, $X$, is a random variable that follows a Cauchy distribution centered at the true peak energy $E$. The probability density function (PDF) for a single measurement $X$ (in electron-volts, eV), assuming a scale parameter of one, is given by:\n$$f(x; E) = \\frac{1}{\\pi [1 + (x - E)^2]}$$\nwhere $E$ is the true, but unknown, peak energy. The corresponding cumulative distribution function (CDF) is:\n$$F(x; E) = \\frac{1}{2} + \\frac{1}{\\pi} \\arctan(x - E)$$\nThe physicist wishes to test if the experimental reality aligns with the theoretical prediction. The null hypothesis, $H_0$, is that the true peak energy is equal to the theoretical prediction, $E_0 = 2.5$ eV. The alternative hypothesis, $H_A$, is that the true peak energy is not equal to $E_0$.\n\nA single, careful measurement is performed, yielding the result $x_{obs} = 2.5 + \\sqrt{3}$ eV.\n\nCalculate the p-value for this two-sided hypothesis test based on this single observation. Recall that the p-value is the probability of obtaining a result at least as extreme as the one observed, assuming the null hypothesis is true. Express your answer as a decimal rounded to three significant figures.", "solution": "Under the null hypothesis, $H_{0}: E = E_{0}$, the observation $X$ has the Cauchy distribution with location $E_{0}$ and scale $1$, with CDF\n$$\nF(x;E_{0}) = \\frac{1}{2} + \\frac{1}{\\pi}\\arctan(x - E_{0}).\n$$\nThe observed value is $x_{\\text{obs}} = E_{0} + \\sqrt{3}$, so the tail probability to the right is\n$$\n1 - F(x_{\\text{obs}};E_{0}) = 1 - \\left(\\frac{1}{2} + \\frac{1}{\\pi}\\arctan(\\sqrt{3})\\right) = \\frac{1}{2} - \\frac{1}{\\pi}\\arctan(\\sqrt{3}).\n$$\nFor a two-sided test with a symmetric distribution about $E_{0}$, the p-value is the probability of an outcome at least as extreme in absolute deviation, which equals\n$$\np = \\mathbb{P}(|X - E_{0}| \\geq |x_{\\text{obs}} - E_{0}| \\mid H_{0}) = 2\\left[1 - F(x_{\\text{obs}};E_{0})\\right].\n$$\nTherefore,\n$$\np = 2\\left(\\frac{1}{2} - \\frac{1}{\\pi}\\arctan(\\sqrt{3})\\right) = 1 - \\frac{2}{\\pi}\\arctan(\\sqrt{3}).\n$$\nUsing the exact identity $\\arctan(\\sqrt{3}) = \\frac{\\pi}{3}$, we obtain\n$$\np = 1 - \\frac{2}{\\pi}\\cdot \\frac{\\pi}{3} = 1 - \\frac{2}{3} = \\frac{1}{3}.\n$$\nAs a decimal rounded to three significant figures,\n$$\np = 0.333.\n$$", "answer": "$$\\boxed{0.333}$$", "id": "1955212"}, {"introduction": "Most real-world scientific questions involve composite hypotheses, where the hypothesis does not uniquely specify all parameters of the underlying probability model. This practice problem walks you through one of the most common scenarios in experimental science: comparing the means of two groups when their population variance is unknown [@problem_id:1955243]. You will apply the pooled two-sample t-test, a cornerstone of statistical inference, to evaluate the effectiveness of an experimental drug based on sample data.", "problem": "A clinical research team is evaluating a new experimental drug intended to lower systolic blood pressure. To do this, they conduct a randomized controlled trial. A group of 45 volunteers with high blood pressure is randomly divided into two groups. The first group, consisting of $n_1 = 25$ individuals, receives the new drug. The second group, consisting of $n_2 = 20$ individuals, receives a placebo.\n\nAfter a treatment period of six weeks, the change in systolic blood pressure is measured for each participant. For the drug group, the sample mean change was $\\bar{x}_1 = -12.1$ mmHg, with a sample standard deviation of $s_1 = 8.0$ mmHg. For the placebo group, the sample mean change was $\\bar{x}_2 = -2.3$ mmHg, with a sample standard deviation of $s_2 = 7.5$ mmHg. A negative value indicates a reduction in blood pressure.\n\nThe researchers wish to test if the drug has a different effect on systolic blood pressure compared to the placebo. They assume that the changes in blood pressure for both populations (drug and placebo) are normally distributed and that the population variances are equal but unknown. Using a significance level of $\\alpha = 0.05$, determine the most appropriate conclusion from the following options.\n\nA. The evidence is statistically significant to conclude that the drug's effect on systolic blood pressure is different from that of the placebo.\n\nB. There is insufficient statistical evidence to conclude that the drug's effect on systolic blood pressure is different from that of the placebo.\n\nC. The data proves that the drug is effective in lowering systolic blood pressure.\n\nD. The null hypothesis is not rejected, which confirms that the true mean change in blood pressure is the same for both the drug and the placebo.\n\nE. Since the sample mean reduction for the drug group is larger than for the placebo group, it is certain that the drug is more effective.", "solution": "We are asked to compare the mean change in systolic blood pressure between a drug group and a placebo group under the assumptions of normality and equal but unknown variances. We test\n$$\nH_{0}:\\ \\mu_{1}-\\mu_{2}=0\n\\quad \\text{vs.} \\quad\nH_{1}:\\ \\mu_{1}-\\mu_{2}\\neq 0,\n$$\nat significance level $\\alpha=0.05$, where $\\mu_{1}$ is the population mean change for the drug and $\\mu_{2}$ is that for the placebo.\n\nBecause equal variances are assumed, we use the pooled two-sample $t$-test. The pooled variance estimator is\n$$\ns_{p}^{2}=\\frac{(n_{1}-1)s_{1}^{2}+(n_{2}-1)s_{2}^{2}}{n_{1}+n_{2}-2}.\n$$\nWith $n_{1}=25$, $s_{1}=8.0$, $n_{2}=20$, $s_{2}=7.5$, we compute\n$$\ns_{1}^{2}=64,\\quad s_{2}^{2}=56.25,\n$$\n$$\n(n_{1}-1)s_{1}^{2}=24\\cdot 64=1536,\\quad (n_{2}-1)s_{2}^{2}=19\\cdot 56.25=1068.75,\n$$\n$$\ns_{p}^{2}=\\frac{1536+1068.75}{25+20-2}=\\frac{2604.75}{43}\\approx 60.57,\n\\quad\ns_{p}\\approx \\sqrt{60.57}\\approx 7.787.\n$$\nThe standard error of $\\bar{x}_{1}-\\bar{x}_{2}$ under the pooled model is\n$$\n\\operatorname{SE}=s_{p}\\sqrt{\\frac{1}{n_{1}}+\\frac{1}{n_{2}}}\n=s_{p}\\sqrt{\\frac{1}{25}+\\frac{1}{20}}\n=s_{p}\\sqrt{0.04+0.05}\n=s_{p}\\sqrt{0.09}\n=0.3\\,s_{p}\\approx 2.336.\n$$\nThe test statistic is\n$$\nt=\\frac{(\\bar{x}_{1}-\\bar{x}_{2})-0}{\\operatorname{SE}}\n=\\frac{(-12.1)-(-2.3)}{2.336}\n=\\frac{-9.8}{2.336}\n\\approx -4.20.\n$$\nUnder $H_{0}$, this statistic follows a $t$ distribution with $n_{1}+n_{2}-2=43$ degrees of freedom. For a two-sided test at $\\alpha=0.05$, the critical value is $t_{0.025,43}\\approx 2.016$. Since\n$$\n|t|\\approx 4.202.016,\n$$\nwe reject $H_{0}$.\n\nTherefore, there is statistically significant evidence at $\\alpha=0.05$ that the mean change in systolic blood pressure differs between the drug and placebo groups. Among the options, this corresponds to option A. Options C and E are incorrect because statistical significance does not prove effectiveness with certainty; option D is incorrect both because we reject $H_{0}$ here and, in general, failing to reject does not confirm equality of means.", "answer": "$$\\boxed{A}$$", "id": "1955243"}]}